Lung Cancer
Thomas J. Lynch, Jr, MD
Yale Cancer Center
Pioneer of personalized medicine
- Director, Yale Cancer Center and Physician-in-Chief, Smilow Cancer Hospital at Yale-New Haven.
- Pioneered the use of molecular testing for mutations in the epidermal growth factor receptor (EGFR) gene to select patients who can benefit from targeted lung cancer therapies.
- Internationally known for his leadership in the development of novel therapies for the treatment of lung cancer.
- Pioneer in the field of personalized medicine.
